Your browser doesn't support javascript.
loading
ADP protects cardiac mitochondria under severe oxidative stress.
Sokolova, Niina; Pan, Shi; Provazza, Sarah; Beutner, Gisela; Vendelin, Marko; Birkedal, Rikke; Sheu, Shey-Shing.
Affiliation
  • Sokolova N; Institute of Cybernetics, Tallinn University of Technology, Tallinn, Estonia.
  • Pan S; Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
  • Provazza S; Department of Pharmacology and Physiology, University of Rochester, Rochester, New York, United States of America.
  • Beutner G; Department of Pharmacology and Physiology, University of Rochester, Rochester, New York, United States of America.
  • Vendelin M; Institute of Cybernetics, Tallinn University of Technology, Tallinn, Estonia.
  • Birkedal R; Institute of Cybernetics, Tallinn University of Technology, Tallinn, Estonia.
  • Sheu SS; Department of Pharmacology and Physiology, University of Rochester, Rochester, New York, United States of America ; Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
PLoS One ; 8(12): e83214, 2013.
Article in En | MEDLINE | ID: mdl-24349464
ABSTRACT
ADP is not only a key substrate for ATP generation, but also a potent inhibitor of mitochondrial permeability transition pore (mPTP). In this study, we assessed how oxidative stress affects the potency of ADP as an mPTP inhibitor and whether its reduction of reactive oxygen species (ROS) production might be involved. We determined quantitatively the effects of ADP on mitochondrial Ca(2+) retention capacity (CRC) until the induction of mPTP in normal and stressed isolated cardiac mitochondria. We used two models of chronic oxidative stress (old and diabetic mice) and two models of acute oxidative stress (ischemia reperfusion (IR) and tert-butyl hydroperoxide (t-BH)). In control mitochondria, the CRC was 344 ± 32 nmol/mg protein. 500 µmol/L ADP increased CRC to 774 ± 65 nmol/mg protein. This effect of ADP seemed to relate to its concentration as 50 µmol/L had a significantly smaller effect. Also, oligomycin, which inhibits the conversion of ADP to ATP by F0F1ATPase, significantly increased the effect of 50 µmol/L ADP. Chronic oxidative stress did not affect CRC or the effect of 500 µmol/L ADP. After IR or t-BH exposure, CRC was drastically reduced to 1 ± 0.2 and 32 ± 4 nmol/mg protein, respectively. Surprisingly, ADP increased the CRC to 447 ± 105 and 514 ± 103 nmol/mg protein in IR and t-BH, respectively. Thus, it increased CRC by the same amount as in control. In control mitochondria, ADP decreased both substrate and Ca(2+)-induced increase of ROS. However, in t-BH mitochondria the effect of ADP on ROS was relatively small. We conclude that ADP potently restores CRC capacity in severely stressed mitochondria. This effect is most likely not related to a reduction in ROS production. As the effect of ADP relates to its concentration, increased ADP as occurs in the pathophysiological situation may protect mitochondrial integrity and function.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / Adenosine Diphosphate / Calcium / Reactive Oxygen Species / Oxidative Stress / Mitochondria, Heart Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: Estonia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myocardial Reperfusion Injury / Adenosine Diphosphate / Calcium / Reactive Oxygen Species / Oxidative Stress / Mitochondria, Heart Type of study: Prognostic_studies Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2013 Document type: Article Affiliation country: Estonia